Skip to main content

Table 1 Clinical characteristics of patients with malignant tumors, benign tumors, thrombi and pseudotumors

From: Evaluation of cardiac masses by real-time perfusion imaging echocardiography

Variables

Malignant (n = 23)

Benign (n = 24)

Thrombi (n = 33)

Pseudotumors (n = 6)

P

Age (years)

45.7 ± 19.2

46.8 ± 19.3

53.0 ± 16.2

52.5 ± 11.0

Female gender

12 (52.2%)

16 (64%)

17 (51.5%)

4 (57.1%)

Weight (Kg)

69.2 ± 20.6

63.0 ± 20.0

63.11 ± 11.5

77.7 ± 21.3

Height (cm)

165.6 ± 12.2

158.9 ± 13.7

164.0 ± 9.2

163.2 ± 10.1

Body mass index (Kg/m2)

24.8 ± 5.3

24.4 ± 6.2

23.4 ± 3.4

29.1 ± 7.1

Cardiovascular history

  Hypertension

7 (30.4%)

13 (52%)

15 (45.5%)

3 (42.8%)

  Diabetes

4 (17.4%)

4 (16%)

4 (12.1%)

2 (28.6%)

  Coronary artery disease

1 (4.3%)

3 (12%)

9 (27.3%)

1 (14.3%)

  Dilated cardiomyopathy

0

1 (4%)

9 (27.3%)

2 (28.6%)

*

  Congestive heart failure

3 (13.0%)

4 (16%)

17 (51.5%)

3 (42.8%)

*

  Atrial fibrillation

1 (4.3%)

1 (4%)

4 (12.1%)

0

  Embolic event

2 (8.7%)

0

4 (12.1%)

0

  Cerebrovascular accident

1 (4.3%)

4 (16%)

3 (9.0%)

1 (14.3%)

  Valvular heart disease

1 (4.3%)

1 (4%)

9 (27.3%)

0

*

Signs and symptoms

  Dyspnea

15 (65.2%)

5 (20%)

22 (66.7%)

3 (42.8%)

†§

  Fever

1 (4.3%)

0

2 (6.0%)

1 (14.3%)

  Peripheral edema

8 (34.8%)

0

10 (30.3%)

2 (28.6%)

  Dysphagia

4 (17.4%)

1 (4%)

0

0

*

  Chest pain

7 (30.4%)

5 (20%)

3 (9.0%)

1 (14.3%)

  Syncope

1 (4.3%)

1 (4%)

0

0

  Odynophagia

3 (13.0)

0

0

0

  Weight loss

12 (52.2%)

0

7 (21.2%)

0

  Lipothymia

4 (17.4%)

2 (8%)

2 (6.0%)

0

  1. † = not significant between groups; * = p < 0.001 between malignant tumors, benign tumors, thrombi and pseudotumors; § = p < 0.05 between malignant tumors and benign tumors.